- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-23-0028428

Avallac Pharmaceutical LLP
About Avallac Pharmaceutical LLP
Data last updated:
Avallac Pharmaceutical LLP is a limited liability partnership (LLP) based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 May 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAP-2810. Its GSTIN is 23ABPFA7434E1ZJ (Madhya Pradesh).
The LLP has a total obligation of contribution of βΉ21 Lakh. It is led by designated partners including Manoj Kumar Batham and Gajendra Singh Shakya.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at 8/250 Mahadev Nagar Near Hr College, Ahmedabad, Gujarat, India β 382480.
Avallac Pharmaceutical LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0028428).
Recognitions & Rankings of Avallac Pharmaceutical
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address8/250 Mahadev Nagar Near Hr College, Ahmedabad, Gujarat, India β 382480
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Avallac Pharmaceutical LLP FY 2024 filings available
Financial Statement Summary of Avallac Pharmaceutical LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Avallac Pharmaceutical LLP
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Avallac Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Avallac Pharmaceutical LLP
Avallac Pharmaceutical has 6 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar Batham | Designated Partner | 13 May 2019 | 7 Years 5 Months | Current |
| Gajendra Singh Shakya | Designated Partner | 13 May 2019 | 7 Years 5 Months | Current |
| Piyush Gupta Also directs: Kallwik Technologies Private Limited, Moneyfest Private Limited | Designated Partner | 29 Mar 2023 | 3 Years 6 Months | Current |
| Surjeet Kumar | Designated Partner | 29 Mar 2023 | 3 Years 6 Months | Current |
| Shailendra Sharma | Designated Partner | 29 Mar 2023 | 3 Years 6 Months | Current |
| Asutosh Sharma | Designated Partner | 16 Jul 2024 | 2 Years 3 Months | Current |
Charges & Borrowings of Avallac Pharmaceutical LLP
Avallac Pharmaceutical LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Avallac Pharmaceutical LLP
Employment history and EPFO contributions of people linked to Avallac Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Avallac Pharmaceutical LLP
Avallac Pharmaceutical LLP has 6 designated partner changes on record since 2019: 6 appointments. The latest: Asutosh Sharma was appointed as Designated Partner on 16 Jul 2024.
Credit Ratings, Litigation & Regulatory Alerts for Avallac Pharmaceutical LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Avallac Pharmaceutical LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Avallac Pharmaceutical LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Avallac Pharmaceutical LLP
Avallac Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23ABPFA7434E1ZJ | Madhya Pradesh | Active | 10 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Avallac Pharmaceutical LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avallac Pharmaceutical LLP
Avallac Pharmaceutical is an active limited liability partnership based in Ahmedabad, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 13 May 2019 (7+ years old) and is registered under LLPIN AAP-2810.
Avallac Pharmaceutical has 6 current designated partners:
- Manoj Kumar Batham - Designated Partner
- Gajendra Singh Shakya - Designated Partner
- Piyush Gupta - Designated Partner
- Surjeet Kumar - Designated Partner
- Shailendra Sharma - Designated Partner
- Asutosh Sharma - Designated Partner
The GSTIN of Avallac Pharmaceutical is 23ABPFA7434E1ZJ, registered in Madhya Pradesh.
The LLPIN (Limited Liability Partnership Identification Number) of Avallac Pharmaceutical is AAP-2810. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Avallac Pharmaceutical was incorporated on 13 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Asutosh Sharma was appointed as Designated Partner on 16 Jul 2024. Piyush Gupta was appointed as Designated Partner on 29 Mar 2023. Shailendra Sharma was appointed as Designated Partner on 29 Mar 2023. Avallac Pharmaceutical has 6 designated partner changes on record in total.
Yes, Avallac Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0028428).
The registered office of Avallac Pharmaceutical is at 8250 Mahadev Nagar Near Hr College, Ahmedabad, Gujarat, India β 382480.
The total obligation of contribution is βΉ21 Lakh.
Avallac Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.